Onkos Wins Fourth FDA Clearance for NanoCept Antibacterial Coating
Image
PARSIPPANY, N.J. – November 06, 2026 -- Onkos Surgical has received its fourth FDA 510(k) clearance for NanoCept Antibacterial Technology since the coating won De Novo authorization in April 2024, extending it to more titanium components of the ELEOS Limb Salvage System.
Clearance covers femurs, tibial baseplates and stems
The new clearance adds proximal femurs, tibial baseplates and augments, and cemented bowed segmental stems to the NanoCept portfolio. It also permits broader NanoCept coverage on titanium components that were previously cleared.
The decision follows an earlier clearance this year that applied NanoCept to titanium implants.